Clinical Trials Directory

PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study

Phase III Study of MR-Guided Focused Ultrasound Surgery for the Treatment of Uterine Fibroids Compared to Myomectomy

Gene Therapy for Fanconi Anemia, Complementation Group A

Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder

Peer Support For Young Adult Women With High Breast Cancer Risk

Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC)

Study of Neodent Implantable Devices of GM Zygomatic Line

Calorie Restriction in Multiple Sclerosis

Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer

HEALEY ALS Platform Trial - Master Protocol

Evaluation of Regeneten Augmentation for Subscapularis Healing After Total Shoulder Arthroplasty (RESTOR)

CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer

AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid

Behavioral Economics Trial To Enhance Regulation of Blood Pressure (BETTER-BP)

Linerixibat Long-term Safety, and Tolerability Study

Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Timing of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African Americans

Ovarian Tissue Cryopreservation in the Setting of Gender-affirming Therapy

Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:

A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)

Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

A Single Arm, Phase Ib/II Trial of Single Agent Pacritinib in Patients With 1q21.3 Amplified Solid Tumors Enriching for Interleukin-1 Receptor-associated Kinase 1 Pathway Activation (PAIR)

INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

MARGetuximab Or Trastuzumab (MARGOT)

Assessing the Immunogenicity of pING-hHER3FL

LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients

Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

KRDI in Transplant-Eligible MM

The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)

A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors

PREPARE: Patient Centered Perioperative Experience

RejuvenAir® System Trial for COPD With Chronic Bronchitis

Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen

Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields

The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation

A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A

A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors

Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia

The Family Stress Study - Chronic Stress and Child Adiposity: Testing a Bio-behavioural Model

Ibrutinib + Venetoclax in Untreated WM

A Study of DS-1001b in Patients With Chemotherapy- and Radiotherapy-Naive IDH1 Mutated WHO Grade II Glioma

Quality of Life Model for Older Patients With AML

Bilateral Essential Tremor Treatment With FUS

Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)

Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma

RETHINK REFLUX Registry

The OPTIMAL Randomized Controlled Trial